Mercola
Story at-a-glance
- A Stanford University geneticist announced work on a “superhero” DNA shot that would use genetic traits from people resilient to disease as a blueprint to repair your cells
- Clinical trials of a single component are set to start as early as 2026, with a combination “vaccine” available within 15 years; the scientist hopes to use it on adults with serious clinical conditions before releasing it to the general public and children
- The Human Genome Project discovered chronic diseases are not controlled by a single gene but rather a complex combination of mutations, environmental factors and your gut microbiome
- COVID-19 and the fear generated by multiple governments may have been the motivational factor that ultimately encouraged people to take a genetic therapy experiment in the COVID vaccine
- Scientists anticipate the “superhero vaccine” may lower the risk of heart disease by 50%, yet health experts estimate making lifestyle changes could lower the death rate from heart disease by 80%
READ FULL ARTICLE HERE > https://articles.mercola.com/sites/articles/archive/2021/07/13/superhero-vaccine.aspx